Remicade

Made by

• Mitsubishi Tanabe Pharma

Active Ingredient

Infliximab

Prospectus

Approval date

2002/1/17

Treats

• Crohn disease
• Behcet disease, Behcet syndrome
• Psoriasis
• Kawasaki disease, Mucocutaneous lymph node syndrome
• Ankylosing spondylitis, Bechterew disease
• Ulcerative colitis
• Pustular psoriasis
• Rheumatoid arthritis

Dosages

• REMICADE for I.V.Infusion - 70597円／瓶